Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Inside the Lab Microbiology and immunology, Screening and monitoring, Clinical care, Laboratory management

Exosome Exploration

“There is a critical need for time-sensitive, noninvasive biomarkers to monitor transplant organ rejection or injury,” says Prashanth Vallabhajosyula, assistant professor of surgery at the Hospital of the University of Pennsylvania. “In transplant patients, complications associated with transplant organ rejection/injury, and with the required immunosuppressive drugs, are the major causes of morbidity and mortality. Therefore, any biomarker platform that can accurately enable noninvasive monitoring of the transplanted organ would have a direct translational impact.” To that end, Vallabhajosyula and a team of researchers (also from the University of Pennsylvania) showed that blood-based transplant exosomes can be a noninvasive alternative to needle biopsy in islet and renal transplants (1).

The investigators transplanted human islets xenogeneically into mice and found that transplanted islets undergoing rejection quickly expressed a lower level of exosome signaling via miRNA. “I was expecting to see changes in transplant tissue-specific exosomes in a time-specific manner, but it surprised me to see the changes occur so early in the acute rejection process – when there was minimal T cell infiltration and no damage of the allograft,” says Vallabhajosyula. “We sincerely believe that our proposed exosome platform will enable development of a noninvasive biomarker for monitoring transplanted tissues – and that means earlier detection of rejection, minimized need for frequent tissue biopsy of the transplanted tissue, and titration of immunosuppression based on the status of the transplanted organ.”

But that’s not all; Vallabhajosyula suggests that transplant tissue exosomes could be manipulated in vitro and then reintroduced into the host... The first glimpse of a new therapy on the horizon?

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. P Vallabhajosyula et al., “Tissue-specific exome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue”, The Journal of Clinical Investigation, 127, 1375–1391 (2017). PMID: 28319051.
About the Author
William Aryitey

My fascination with science, gaming, and writing led to my studying biology at university, while simultaneously working as an online games journalist. After university, I travelled across Europe, working on a novel and developing a game, before finding my way to Texere. As Associate Editor, I’m evolving my loves of science and writing, while continuing to pursue my passion for gaming and creative writing in a personal capacity.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register